Inhibition of invadopodia formation by diosgenin in tumor cells (Review)
- Authors:
- Yaxin Lian
- Dezhong Wen
- Xiaoting Meng
- Xiaozhen Wang
- Hongcheng Li
- Liming Hao
- Hui Xue
- Jia Zhao
-
Affiliations: Department of Histology and Embryology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin 130021, P.R. China, Department of Medical Genetics, College of Basic Medical Sciences, Jilin University, Changchun, Jilin 130021, P.R. China, Department of Breast Surgery, The First Hospital, Jilin University, Changchun, Jilin 130021, P.R. China, GeneScience Pharmaceuticals Co., Ltd., Changchun, Jilin 130021, P.R. China - Published online on: September 23, 2020 https://doi.org/10.3892/ol.2020.12148
- Article Number: 283
-
Copyright: © Lian et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
|
Torre LA, Siegel RL, Ward EM and Jemal A: Global cancer incidence and mortality rates and trends-an update. Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016.PubMed/NCBI | |
|
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.PubMed/NCBI | |
|
Zeeshan R and Mutahir Z: Cancer metastasis-tricks of the trade. Bosn J Basic Med Sci. 17:172–182. 2017.PubMed/NCBI | |
|
Dudjak LA: Cancer metastasis. Semin Oncol Nurs. 8:40–50. 1992.PubMed/NCBI | |
|
Yang J and Weinberg RA: Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Dev Cell. 14:818–829. 2008.PubMed/NCBI | |
|
Valastyan S and Weinberg R: Tumor metastasis: Molecular insights and evolving paradigms. Cell. 147:275–292. 2011.PubMed/NCBI | |
|
Linder S and Wiesner C: Tools of the trade: Podosomes as multipurpose organelles of monocytic cells. Cell Mol Life Sci. 72:121–135. 2015.PubMed/NCBI | |
|
Popow-Woźniak A, Mazur AJ, Mannherz HG, Malicka-Błaszkiewicz M and Nowak D: Cofilin overexpression affects actin cytoskeleton organization and migration of human colon adenocarcinoma cells. Histochem Cell Biol. 138:725–736. 2012.PubMed/NCBI | |
|
Leong H, Robertson A, Stoletov K, Leith SJ, Chin CA, Chien AE, Hague MN, Ablack A, Carmine-Simmen K, McPherson VA, et al: Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasis. Cell Rep. 8:1558–1570. 2014.PubMed/NCBI | |
|
Parekh A and Weaver AM: Regulation of invadopodia by mechanical signaling. Exp Cell Res. 343:89–95. 2016.PubMed/NCBI | |
|
Artym VV, Yamada KM and Mueller SC: ECM Degradation assays for analyzing local cell invasion. Methods Mol Biol. 522:211–219. 2009.PubMed/NCBI | |
|
Beaty BT and Condeelis J: Digging a little deeper: The stages of invadopodium formation and maturation. Eur J Cell Biol. 93:438–444. 2014.PubMed/NCBI | |
|
Eddy RJ, Weidmann MD, Sharma VP and Condeelis JS: Tumor cell invadopodia: Invasive protrusions that orchestrate metastasis. Trends Cell Biol. 27:595–607. 2017.PubMed/NCBI | |
|
Sharma V, Eddy R, Entenberg D, Kai M, Gertler FB and Condeelis J: Tks5 and SHIP2 regulate invadopodium maturation, but not initiation, in breast carcinoma cells. Curr Biol. 23:2079–2089. 2013.PubMed/NCBI | |
|
Hughes SK, Oudin MJ, Tadros J, Neil J, Del Rosario A, Joughin BA, Ritsma L, Wyckoff J, Vasile E, Eddy R, et al: PTP1B-dependent regulation of receptor tyrosine kinase signaling by the actin-binding protein Mena. Mol Biol Cell. 26:3867–3878. 2015.PubMed/NCBI | |
|
Zervantonakis I, Sudo R, Rimchala T, Chung S and Kamm R: Abstract #2269: A physiological relevant 3D in vitro model of cancer cell migration and interactions with endothelium. Cancer Res. 69:2269. 2009.PubMed/NCBI | |
|
Wang DD, Chen YB, Zhao JJ, Zhang XF, Zhu GC, Weng DS, Pan K, Lv L, Pan QZ, Jiang SS, et al: TES functions as a Mena-dependent tumor suppressor in gastric cancer carcinogenesis and metastasis. Cancer Commun (Lond). 39:32019.PubMed/NCBI | |
|
Bravo-Cordero JJ, Magalhaes MA, Eddy RJ, Hodgson L and Condeelis J: Functions of cofilin in cell locomotion and invasion. Nat Rev Mol Cell Biol. 14:405–415. 2013.PubMed/NCBI | |
|
Murphy DA and Courtneidge SA: The ‘ins’ and ‘outs’ of podosomes and invadopodia: Characteristics, formation and function. Nat Rev Mol Cell Biol. 12:413–426. 2011.PubMed/NCBI | |
|
Linder S: The matrix corroded: Podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol. 17:107–117. 2007.PubMed/NCBI | |
|
Baldassarre M, Pompeo A, Beznoussenko G, Castaldi C, Cortellino S, McNiven MA, Luini A and Buccione R: Dynamin participates in focal extracellular matrix degradation by invasive cells. Mol Biol Cell. 14:1074–1084. 2003.PubMed/NCBI | |
|
Buccione R, Orth JD and McNiven MA: Foot and mouth: Podosomes, invadopodia and circular dorsal Ruffles. Nat Rev Mol Cell Biol. 5:647–657. 2004.PubMed/NCBI | |
|
Chuang YY: Role of synaptojanin 2 in glioma cell migration and invasion. Cancer Res. 64:8271–8275. 2004.PubMed/NCBI | |
|
Tu Y: The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med. 17:1217–1220. 2011.PubMed/NCBI | |
|
Wang YJ, Pan KL, Hsieh TC, Chang TY, Lin WH and Hsu JT: Diosgenin, a plant-derived sapogenin, exhibits antiviral activity in vitro against hepatitis c virus. J Nat Prod. 74:580–584. 2011.PubMed/NCBI | |
|
Cayen MN and Dvornik D: Effect of diosgenin on lipid metabolism in rats. J Lipid Res. 20:1621979.PubMed/NCBI | |
|
Chen Y, Tang YM, Yu SL, Han YW, Kou JP, Liu BL and Yu BY: Advances in the pharmacological activities and mechanisms of diosgenin. Chin J Nat Med. 13:578–587. 2015.PubMed/NCBI | |
|
Li F, Fernandez PP, Rajendran P, Hui KM and Sethi G: Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells. Cancer Lett. 292:197–207. 2010.PubMed/NCBI | |
|
Tao X, Yin L, Xu L and Peng J: Dioscin: A diverse acting natural compound with therapeutic potential in metabolic diseases, cancer, inflammation and infections. Pharmacol Res. 137:259–269. 2018.PubMed/NCBI | |
|
Sethi G, Shanmugam MK, Warrier S, Merarchi M, Arfuso F, Kumar AP and Bishayee A: Pro-Apoptotic and Anti-cancer properties of diosgenin: A comprehensive and critical review. Nutrients. 10:6452018. | |
|
Ma HY, Zhou LL and Wang BX: Antagonistic effect of DX and diosgenin on hyperlipidemia induced by cholesterol in vivo and on blood platelet aggregation in vitro. Chin J Hos Pharmacy. 22:323–325. 2002. | |
|
Raju J and Mehta R: Cancer chemopreventive and therapeutic effects of diosgenin, a food saponin. Nutr Cancer. 61:27–35. 2009.PubMed/NCBI | |
|
Chen PS, Shih YW, Huang HC and Cheng HW: Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer pc-3 cells by reducing matrix metalloproteinases expression. PLoS One. 6:e201642011.PubMed/NCBI | |
|
Nie C, Zhou J, Qin X, Shi X, Zeng Q, Liu J, Yan S and Zhang L: Diosgenin-induced autophagy and apoptosis in a human prostate cancer cell line. Mol Med Rep. 14:4349–4359. 2016.PubMed/NCBI | |
|
Sun GC, Jan CR and Liang WZ: Exploring the impact of a naturally occurring sapogenin diosgenin on underlying mechanisms of Ca2+ movement and cytotoxicity in human prostate cancer cells. Environ Toxicol. 35:395–403. 2020.PubMed/NCBI | |
|
Hu M, Xu L, Yin L, Qi Y, Li H, Xu Y, Han X, Peng J and Wan X: Cytotoxicity of dioscin in human gastric carcinoma cells through death receptor and mitochondrial pathways. J Appl Toxicol. 33:712–722. 2013.PubMed/NCBI | |
|
Zhao X, Xu L, Zheng L, Yin L, Qi Y, Han X, Xu Y and Peng J: Potent effects of dioscin against gastric cancer in vitro and in vivo. Phytomedicine. 23:274–282. 2016.PubMed/NCBI | |
|
Rahmati-Yamchi M, Ghareghomi S, Haddadchi G, Milani M, Aghazadeh M and Daroushnejad H: Fenugreek extract diosgenin and pure diosgenin inhibit the htert gene expression in a549 lung cancer cell line. Mol Biol Rep. 41:6247–6252. 2014.PubMed/NCBI | |
|
Xu L, Xu D, Li Z, Gao Y and Chen H: Synthesis and potent cytotoxic activity of a novel diosgenin derivative and its phytosomes against lung cancer cells. Beilstein J Nanotechnol. 10:1933–1942. 2019.PubMed/NCBI | |
|
Srinivasan S, Koduru S, Kumar R, Venguswamy G, Kyprianou N and Damodaran C: Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells. Int J Cancer. 125:961–967. 2009.PubMed/NCBI | |
|
Swamy MV, Patlolla JM, Jayadev R, Marcus LA, Choi CI and Rao CV: Chemoprevention of colon cancer by diosgenin, a steroidal saponin constituent of fenugreek. Cancer Res. 652005. | |
|
Shishodia S and Aggarwal BB: Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, I kappa B kinase activation and NF-kappa B-regulated gene expression. Oncogene. 25:1463–1473. 2006.PubMed/NCBI | |
|
Liagre B, Bertrand J, Leger DY and Beneytout JL: Diosgenin, a plant steroid, induces apoptosis in COX-2 deficient K562 cells with activation of the p38 MAP kinase signalling and inhibition of NF-kappaB binding. Int J Mol Med. 16:1095–1101. 2005.PubMed/NCBI | |
|
Cai H, Gong L, Liu J, Zhou Q and Zheng Z: Diosgenin inhibits tumor angiogenesis through regulating GRP78-mediated HIF-1α and VEGF/VEGFR signaling pathways. Pharmazie. 74:680–684. 2019.PubMed/NCBI | |
|
Lepage C, Léger DY, Bertrand J, Martin F, Beneytout JL and Liagre B: Diosgenin induces death receptor-5 through activation of p38 pathway and promotes TRAIL-induced apoptosis in colon cancer cells. Cancer Lett. 301:193–202. 2011.PubMed/NCBI | |
|
Fang K, Dong H, Jiang S, Li F, Wang D, Yang D, Gong J, Huang W and Lu F: Diosgenin and 5-Methoxypsoralen ameliorate insulin resistance through ER-α/PI3K/Akt-signaling pathways in HepG2 cells. Evid Based Complement Alternat Med. 2016:74936942016.PubMed/NCBI | |
|
Corbiere C, Liagre B, Bianchi A, Bordji K, Dauça M, Netter P and Beneytout JL: Different contribution of apoptosis to the antiproliferative effects of diosgenin and other plant steroids, hecogenin and tigogenin, on human 1547 osteosarcoma cells. Int J Oncol. 22:899–905. 2003.PubMed/NCBI | |
|
Corbiere C, Liagre B, Terro F and Beneytout JL: Induction of antiproliferative effect by diosgenin through activation of p53, release of apoptosis-inducing factor (AIF) and modulation of caspase-3 activity in different human cancer cells. Cell Res. 14:188–196. 2004.PubMed/NCBI | |
|
Wang WC, Liu SF, Chang WT, Shiue YL, Hsieh PF, Hung TJ, Hung CY, Hung YJ, Chen MF and Yang YL: The effects of diosgenin in the Regulation of renal proximal tubular fibrosis. Exp Cell Res. 323:255–262. 2014.PubMed/NCBI | |
|
He Z, Chen H, Li G, Zhu H, Gao Y, Zhang L and Sun J: Diosgenin inhibits the migration of human breast cancer MDA-MB-231 cells by suppressing Vav2 activity. Phytomedicine. 21:871–876. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wani SA and Kumar P. Fenugreek: A review on its nutraceutical properties and utilization in various food products. J Saudi Soc Agricultural Sci. 17:97–106. 2018. | |
|
Wang C, Huo X, Wang L, Meng Q, Liu Z, Liu Q, Sun H, Sun P, Peng J and Liu K: Dioscin strengthens the efficiency of Adriamycin in MCF-7 and MCF-7/ADR cells through autophagy induction: More than just down-regulation of MDR1. Sci Rep. 6:284032016. View Article : Google Scholar : PubMed/NCBI | |
|
Belsches AP, Haskell MD and Parsons SJ: Role of c-Src tyrosine kinase in EGF-induced mitogenesis. Front Biosci. 2:d501–d518. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Yin M, Ma W and An L: Cortactin in cancer cell migration and invasion. Oncotarget. 8:88232–88243. 2015. View Article : Google Scholar | |
|
Chien HT, Cheng SD, Chuang WY, Liao CT, Wang HM and Huang SF: Clinical implications of fadd gene amplification and protein overexpression in taiwanese oral cavity squamous cell carcinomas. PLoS One. 11:e01648702016. View Article : Google Scholar : PubMed/NCBI | |
|
Bryce NS, Clark ES, Leysath JL, Currie JD, Webb DJ and Weaver AM: Cortactin promotes cell motility by enhancing lamellipodial persistence. Curr Biol. 15:1276–1285. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Uruno T, Liu J, Li Y, Smith N and Zhan X: Sequential interaction of actin-related proteins 2 and 3 (Arp2/3) complex with neural Wiscott-Aldrich syndrome protein (N-WASP) and cortactin during branched actin filament network formation. J Biol Chem. 278:26086–26093. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Cosenbinker LI and Kapus A: Cortactin: The gray eminence of the cytoskeleton. Physiology (Bethesda). 21:352–361. 2006.PubMed/NCBI | |
|
Mizutani K, Miki H, He H, Maruta H and Takenawa T: Essential role of neural Wiskott-Aldrich syndrome protein in podosome formation and degradation of extracellular matrix in src-transformed fibroblasts. Cancer Res. 62:669–674. 2002.PubMed/NCBI | |
|
Kinley AW, Weed SA, Weaver AM, Karginov AV, Bissonette E, Cooper JA and Parsons JT: Cortactin Interacts with WIP in regulating Arp2/3 activation and membrane protrusion. Curr Biol. 13:384–393. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Lin J, Liu J, Wang Y, Zhu J, Zhou K, Smith N and Zhan X: Differential regulation of cortactin and N-WASP-mediated actin polymerization by missing in metastasis (MIM) protein. Oncogene. 24:2059–2066. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Buday L and Downward J: Roles of cortactin in tumor pathogenesis. Biochim Biophys Acta. 1775:263–273. 2007.PubMed/NCBI | |
|
He Y, Ren Y, Wu B, Decourt B, Lee AC, Taylor A and Suter DM: Src and cortactin promote lamellipodia protrusion and filopodia formation and stability in growth cones. Mol Biol Cell. 26:3229–3244. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Krueger EW, Orth JD, Cao H and McNiven MA: A Dynamin-Cortactin-Arp2/3 complex mediates actin reorganization in growth factor-stimulated cells. Mol Biol Cell. 14:1085–1096. 2013. View Article : Google Scholar | |
|
Oser M, Yamaguchi H, Mader CC, Bravo-Cordero JJ, Arias M, Chen X, Desmarais V, van Rheenen J, Koleske AJ and Condeelis J: Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation. J Cell Biol. 186:571–587. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ayala I, Baldassarre M, Giacchetti G, Caldieri G, Tetè S, Luini A and Buccione R: Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation. J Cell Sci. 121:369–378. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Ren XL, Qiao YD, Li JY, Li XM, Zhang D, Zhang XJ, Zhu XH, Zhou WJ, Shi J, Wang W, et al: Cortactin recruits FMNL2 to promote actin polymerization and endosome motility in invadopodia formation. Cancer Lett. 419:245–256. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Desmarais V, Yamaguchi H, Oser M, Soon L, Mouneimne G, Sarmiento C, Eddy R and Condeelis J: N-WASP and cortactin are involved in invadopodium-dependent chemotaxis to EGF In breast tumor cells. Cell Motil Cytoskeleton. 66:303–316. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Uruno T, Liu J, Zhang P, Fan YX, Egile C, Li R, Mueller SC and Zhan X: Activation of Arp2/3 complex-mediated actin polymerization by cortactin. Nat Cell Biol. 3:259–266. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Weaver AM, Karginov AV, Kinley AW, Weed SA, Li Y, Parsons JT and Cooper JA: Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation. Curr Biol. 11:370–374. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM and Mueller SC: dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: Defining the stages of invadopodia formation and function. Cancer Res. 66:3034–3043. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Khaitlina SY: Intracellular transport based on actin polymerization. Biochemistry (Mosc). 79:917–927. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ren G, Crampton MS and Yap AS: Cortactin: Coordinating adhesion and the actin cytoskeleton at cellular protrusions. Cell Motil Cytoskeleton. 66:865–873. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Tehrani S, Faccio R, Chandrasekar I, Ross FP and Cooper JA: Cortactin has an essential and specific role in osteoclast actin assembly. Mol Biol Cell. 17:2882–2895. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
van Rossum AG, Moolenaar WH and Schuuring E: Cortactin affects cell migration by regulating intercellular adhesion and cell spreading. Exp Cell Res. 312:1658–1670. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Steven M: Markwell; Amanda Gatesman Ammer, Interval ET, Schafer DA Hames RA and Weed SA: Abstract 5067: Casein kinase 2 alpha phosphorylation of cortactin governs actin cytoskeletal regulation of invadopodia function. Cancer Res. 76 (14 Suppl):S5067. 2016. | |
|
Jeannot P and Besson A: Cortactin function in invadopodia. Small GTPases. 11:256–270. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Meng DF, Xie P, Peng LX, Sun R, Luo DH, Chen QY, Lv X, Wang L, Chen MY, Mai HQ, et al: CDC42-interacting protein 4 promotes metastasis of nasopharyngeal carcinoma by mediating invadopodia formation and activating EGFR signaling. J Exp Clin Cancer Res. 36:212017. View Article : Google Scholar : PubMed/NCBI | |
|
Genna A, Lapetina S, Lukic N, Twafra S, Meirson T, Sharma VP, Condeelis JS and Gil-Henn H: Pyk2 and FAK differentially regulate invadopodia formation and function in breast cancer cells. J Cell Biol. 217:375–395. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Kempiak SJ, Yamaguchi H, Sarmiento C, Sidani M, Ghosh M, Eddy RJ, Desmarais V, Way M, Condeelis J and Segall JE: A Neural Wiskott-aldrich syndrome protein-mediated pathway for localized activation of actin polymerization that is regulated by cortactin. J Biol Chem. 280:5836–5842. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Wang W, Liu Y and Liao K: Tyrosine phosphorylation of cortactin by the FAK-Src complex at focal adhesions regulates cell motility. BMC Cell Biol. 12:492011. View Article : Google Scholar : PubMed/NCBI | |
|
Huang C, Ni Y, Wang T, Gao Y, Haudenschild CC and Zhan X: Down-regulation of the filamentous actin cross-linking activity of cortactin by Src-mediated tyrosine phosphorylation. J Biol Chem. 272:13911–13915. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Leger DY, Liagre B and Beneytout JL: Role of MAPKs and NF-kappaB in diosgenin-induced megakaryocytic differentiation and subsequent apoptosis in HEL cells. Int J Oncol. 28:201–207. 2006.PubMed/NCBI | |
|
Siar CH, Rahman ZA, Tsujigiwa H, Mohamed OM, Alblazi K, Nagatsuka H and Ng KH: Invadopodia proteins, cortactin, N-WASP and WIP differentially promote local invasiveness in ameloblastoma. J Oral Pathol Med. 45:591–598. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Tong Q, Qing Y, Wu Y, Hu X, Jiang L and Wu X: Dioscin inhibits colon tumor growth and tumor angiogenesis through regulating VEGFR2 and AKT/MAPK signaling pathways. Toxicol Appl Pharmacol. 281:166–173. 2014.PubMed/NCBI | |
|
Farhan MA, Azad AK, Touret N and Murray AG: FGD5 Regulates VEGF Receptor-2 Coupling to PI3 kinase and receptor recycling. Arterioscler Thromb Vasc Biol. 37:2301–2310. 2017.PubMed/NCBI | |
|
Choi KW, Park HJ, Jung DH, Kim TW, Park YM, Kim BO, Sohn EH, Moon EY, Um SH, Rhee DK and Pyo S: Inhibition of TNF-α-induced adhesion molecule expression by diosgenin in mouse vascular smooth muscle cells via downregulation of the MAPK, Akt and NF-κB signaling pathways. Vascul Pharmacol. 53:273–280. 2010.PubMed/NCBI | |
|
Li S, Cheng B, Hou L, Huang L, Cui Y, Xu D, Shen X and Li S: Dioscin inhibits colon cancer cells' growth by reactive oxygen species-mediated mitochondrial dysfunction and p38 and JNK pathways. Anticancer Drugs. 29:234–242. 2018.PubMed/NCBI | |
|
Lin SC, Gou GH, Hsia CW, Ho CW, Huang KL, Wu YF, Lee SY and Chen YH: Simulated microgravity disrupts cytoskeleton organization and increases apoptosis of rat neural crest stem cells via upregulating CXCR4 expression and RhoA-ROCK1-p38 MAPK-p53 signaling. Stem Cells Dev. 25:1172–1193. 2016.PubMed/NCBI | |
|
Chiang CT, Way TD, Tsai SJ and Lin JK: Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation. FEBS Lett. 581:5735–5742. 2007.PubMed/NCBI | |
|
Wang YC, Wu DW, Wu TC, Wang L, Chen CY and Lee H: Dioscin overcome TKI resistance in EGFR-mutated lung adenocarcinoma cells via Down-regulation of tyrosine phosphatase SHP2 expression. Int J Biol Sci. 14:47–56. 2018.PubMed/NCBI | |
|
Gao M, Chen L, Yu H, Sun Q, Kou J and Yu B: Diosgenin down-regulates NF-κB p65/p50 and p38MAPK pathways and attenuates acute lung injury induced by lipopolysaccharide in mice. Int Immunopharmacol. 15:240–245. 2013.PubMed/NCBI | |
|
Song JS, Ma L, Kou J and Yu BY: Diosgenin reduces leukocytes adhesion and migration linked with inhibition of intercellular adhesion molecule-1 expression and NF-kB p65 activation in endothelial cells. Chin J Nat Med. 10:142–149. 2012. | |
|
Tavora B, Reynolds LE, Batista S, Demircioglu F, Fernandez I, Lechertier T, Lees DM, Wong PP, Alexopoulou A, Elia G, et al: Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy. Nature. 514:112–116. 2014.PubMed/NCBI | |
|
Liu Z, Zhang HM, Yuan J, Lim T, Sall A, Taylor GA and Yang D: Focal adhesion kinase mediates the interferon-gamma-inducible GTPase-induced phosphatidylinositol 3-kinase/Akt survival pathway and further initiates a positive feedback loop of NF-kappaB activation. Cell Microbiol. 10:1787–1800. 2010. | |
|
Chen J, Zhang W, Wang Y, Zhao D, Wu M, Fan J, Li J, Gong Y, Dan N, Yang D, et al: The diacylglycerol kinase α (DGKα)/Akt/NF-κB feedforward loop promotes esophageal squamous cell carcinoma (ESCC) progression via FAK-dependent and FAK-independent manner. Oncogene. 38:2533–2550. 2019.PubMed/NCBI | |
|
Irby RB and Yeatman TJ: Role of Src expression and activation in human cancer. Oncogene. 19:5636–5642. 2000.PubMed/NCBI | |
|
Zhou X, Yang F, Zhang Q, Miao Y, Hu X, Li A, Hou G, Wang Q and Kang J: FAM129B promoted tumor invasion and proliferation via facilitating the phosphorylation of FAK signaling and associated with adverse clinical outcome of non-small cell lung cancer patients. Onco Targets Ther. 11:7493–7501. 2018.PubMed/NCBI | |
|
Avizienyte E and Frame MC: Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr Opin Cell Biol. 17:542–547. 2005.PubMed/NCBI | |
|
Mitra SK and Schlaepfer DD: Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol. 18:516–523. 2006.PubMed/NCBI | |
|
Liang Y, Yi L, Liu P, Jiang L, Wang H, Hu A, Sun C and Dong J: CX3CL1 involves in breast cancer metastasizing to the spine via the Src/FAK signaling pathway. J Cancer. 9:3603–3612. 2018.PubMed/NCBI | |
|
Saijo K, Schmedt C, Su IH, Karasuyama H, Lowell CA, Reth M, Adachi T, Patke A, Santana A and Tarakhovsky A: Essential role of Src-family protein tyrosine kinases in NF-kappaB activation during B cell development. Nat Immunol. 4:274–279. 2003.PubMed/NCBI | |
|
Chen L, Chen H and Liu F: RACK1 to modulate expression of MMP10 via Src/NF-κB pathway in gastric cancer. J Clin Oncol. 35 (15_suppl):e155292017. | |
|
Lai SW, Bamodu OA, Tsai WC, Chang YM, Lee WH, Yeh CT and Chao TY: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity. Clin Exp Metastasis. 35:663–677. 2018.PubMed/NCBI | |
|
Peng X, Zhang Q, Zeng Y, Li J, Wang L and Ai P: Evodiamine inhibits the migration and invasion of nasopharyngeal carcinoma cells in vitro via repressing MMP-2 expression. Cancer Chemother Pharmacol. 76:1173–1184. 2015.PubMed/NCBI | |
|
Lian S, Xia Y, Khoi PN, Ung TT, Yoon HJ, Kim NH, Kim KK and Jung YD: Cadmium induces matrix metalloproteinase-9 expression via ROS-dependent EGFR, NF-кB, and AP-1 pathways in human endothelial cells. Toxicology. 338:104–116. 2015.PubMed/NCBI | |
|
Hung CY, Lee CH, Chiou HL, Lin CL, Chen PN, Lin MT, Hsieh YH and Chou MC: Praeruptorin-B Inhibits 12-O-tetradecanoylphorbol-13-Acetate-induced cell invasion by targeting AKT/NF-κB via matrix metalloproteinase-2/-9 expression in human cervical cancer cells. Cell Physiol Biochem. 52:1255–1266. 2019.PubMed/NCBI | |
|
Sabir N, Hussain T, Mangi MH, Zhao D and Zhou X: Matrix metalloproteinases: Expression, regulation and role in the immunopathology of tuberculosis. Cell Prolif. 52:e126492019.PubMed/NCBI | |
|
Liu LP, Liang HF, Chen XP, Zhang WG, Yang SL, Xu T and Ren L: The role of NF-kappaB in Hepatitis B virus X protein-mediated upregulation of VEGF and MMPs. Cancer Invest. 28:443–451. 2010.PubMed/NCBI | |
|
Zhang X, Jin M, Tadesse N, Dang J, Zhou T, Zhang H, Wang S, Guo Z and Ito Y: Dioscorea zingiberensis C. H. Wright: An overview on its traditional use, phytochemistry, pharmacology, clinical applications, quality control, and toxicity. J Ethnopharmacol. 220:283–293. 2018.PubMed/NCBI | |
|
Wu FC and Jiang JG: Effects of diosgenin and its derivatives on atherosclerosis. Food Funct. 10:7022–7036.. 2019.PubMed/NCBI | |
|
Tao W, Luo X, Cui B, Liang D, Wang C, Duan Y, Li X, Zhou S, Zhao M, Li Y, et al: Practice of traditional Chinese medicine for psycho-behavioral intervention improves quality of life in cancer patients: A systematic review and meta-analysis. Oncotarget. 6:39725–39739. 2015.PubMed/NCBI | |
|
Wang J, Wong YK and Liao F: What has traditional Chinese medicine delivered for modern medicine? Expert Rev Mol Med. 20:e42018.PubMed/NCBI | |
|
White NJ: Qinghaosu (Artemisinin): The price of success. Science. 320:330–334. 2008.PubMed/NCBI | |
|
Zhou L, Zuo Z and Chow MS: Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol. 45:1345–1349. 2005.PubMed/NCBI | |
|
Yi-Lan LI, Shan-Shan Q and Guo-Xing LI: Effect of glossy ganoderma on antitumor and immune function in mice. Chin J Prevention Control Chronic Non-Communicable Dis. 2004. | |
|
Liu P, Zhao H and Luo Y: Anti-aging implications of astragalus membranaceus (Huangqi): A Well-known Chinese tonic. Aging Dis. 8:868–886. 2017.PubMed/NCBI | |
|
Wang K, Wu J, Duan X, Wu J, Zhang D, Zhang X and Zhang B: Huangqi injection in the treatment of chronic heart failure: A systematic review and meta-analysis. Medicine (Baltimore). 96:e81672017.PubMed/NCBI | |
|
de Martel C, Forman D and Plummer M: Gastric cancer: Epidemiology and risk factors. Gastroenterol Clin North Am. 42:219–240. 2013.PubMed/NCBI | |
|
Camargo MC, Anderson WF, King JB, Correa P, Thomas CC, Rosenberg PS, Eheman CR and Rabkin CS: Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut. 60:1644–169. 2011.PubMed/NCBI | |
|
Steevens J, Botterweck AAM, Dirx MJ, van den Brandt PA and Schouten LJ: Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol. 22:669–678. 2010.PubMed/NCBI |
